LP21307-1
Amprenavir
Active
Description
Amprenavir (Agenerase, GlaxoSmithKline) is a protease inhibitor used to treat HIV infection. Production of amprenavir was discontinued by the manufacturer December 31, 2004; a prodrug version (fosamprenavir) is available. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Wikipedia
Basic Part Properties
- Part Display Name
- Amprenavir
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2001-01-02
- Construct for LOINC Short Name
- Amprenavir
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP21307-1 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP21307-1
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 安普那韦 Synonyms: 安泼那韦 |
| fr-CA | French (Canada) | Amprénavir |
| et-EE | Estonian (Estonia) | Amprenaviir |
| es-ES | Spanish (Spain) | Amprenavir |
| it-IT | Italian (Italy) | Amprenavir |
| tr-TR | Turkish (Turkey) | Amprenavir |
| ru-RU | Russian (Russian Federation) | Ампренавир |
| nl-NL | Dutch (Netherlands) | amprenavir |
| fr-BE | French (Belgium) | Amprénavir |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright